(AEMD) Index Solutions - Index - Overview
Etf: Equity, Emerging Markets, Index, ETF
Dividends
| Dividend Yield | 1.95% |
| Yield on Cost 5y | 2.21% |
| Yield CAGR 5y | -1.06% |
| Payout Consistency | 93.5% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.2% |
| Relative Tail Risk | -3.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.14 |
| Alpha | 19.07 |
| Character TTM | |
|---|---|
| Beta | 0.225 |
| Beta Downside | 0.478 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.92% |
| CAGR/Max DD | 0.77 |
Description: AEMD Index Solutions - Index December 31, 2025
The Amundi Index MSCI Emerging Markets UCITS ETF DR (EUR) – ticker AEMD – is a Germany-domiciled exchange-traded fund that tracks the Morningstar Emerging Markets Total Market Index (EM TME NR) expressed in USD. It provides investors with broad exposure to large-, mid- and small-cap equities across 26 emerging economies, covering roughly 1,500 stocks.
Key metrics as of the latest reporting period include an expense ratio of 0.20% and total assets under management of about €4.2 bn, placing it among the larger Europe-listed EM ETFs. The fund’s top sector allocations are information technology (≈15%), financials (≈14%) and consumer discretionary (≈13%), reflecting the ongoing shift toward digitalisation and rising middle-class consumption in markets such as China, India and Brazil. Recent macro drivers include resilient export demand from emerging markets, a gradual easing of commodity price volatility, and tighter monetary policy cycles in the United States that have modestly pressured capital flows.
For a deeper, data-driven view of AEMD’s risk-adjusted performance and scenario analysis, you may find the analytics on ValueRay worth exploring.
What is the price of AEMD shares?
Over the past week, the price has changed by +1.13%, over one month by +3.52%, over three months by +8.81% and over the past year by +26.48%.
Is AEMD a buy, sell or hold?
What are the forecasts/targets for the AEMD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 71.5 | 10.3% |
AEMD Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 870.2m EUR (870.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 870.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 870.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.74% (E(870.2m)/V(870.2m) * Re(6.74%) + (debt-free company))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)